Peter Rindom Koffeldt
3PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Jul 12, 2025
Refining Criteria for Choosing the First-Line Treatment for Real-World Patients with Advanced ALK-Rearranged NSCLC.Edyta Maria Urbanska, Peter Rindom Koffeldt, Morten Grauslund
|Oct 21, 2024
ALK-tyrosine kinase inhibitor intrinsic resistance due to de novo MET-amplification in metastatic ALK-rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination-case report.Edyta M Urbanska, Morten Grauslund, Siv M S Berger
|Sep 09, 2023
Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR-Mutated NSCLC.Edyta M Urbanska, Morten Grauslund, Peter R Koffeldt
Pageof 1
